Clinical Trial: A Single-Arm Study Evaluating the Effectiveness and Safety of Suzetrigine (SUZ) for Acute Pain After Aesthetic or Reconstructive Surgeries

U.S., March 22 -- ClinicalTrials.gov registry received information related to the study (NCT06887972) titled 'A Single-Arm Study Evaluating the Effectiveness and Safety of Suzetrigine (SUZ) for Acute Pain After Aesthetic or Reconstructive Surgeries' on March 19.

Brief Summary: The purpose of this study to evaluate the effectiveness, safety, and tolerability of SUZ as part of multimodal therapy (MMT) in treating acute postoperative pain.

Study Start Date: March 28

Study Type: INTERVENTIONAL

Condition: Acute Pain

Intervention: DRUG: Suzetrigine

Tablets for oral administration.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Vertex Pharmaceuticals Incorporated

Published by HT Digital Content Services with permission from Health Dail...